Avalyn Pharma to Attend Three Investor Conferences
Avalyn Pharma announced it will participate in three investor conferences.
Related stories
Palantir Raises 2026 Revenue Guidance After Q3 Revenue Climbs 96%
Palantir reported Q3 revenue of $2.313B, up 96% year over year, and raised full-year 2026 revenue guidance to $8.530B—$8.534B. U.S. commercial revenue was $984M, up 148%.
M impact | EQUITY | Nov 03, 2026, 04:32 PM UTC
Toyota Motor North America U.S. Electrified Sales Rise 34.6% in October
Toyota Motor North America reported 126,054 U.S. electrified vehicle sales in October 2026, up 34.6% on a volume basis.
M impact | EQUITY | Nov 03, 2026, 04:32 PM UTC
Dow Falls While Nasdaq Rises in Election Day Trading
Tuesday’s session reversed the previous pattern, with the Dow lower and the Nasdaq higher.
M impact | EQUITY | Nov 03, 2026, 04:32 PM UTC
Supermarket Income REIT Raises £60 Million in Share Issue
Supermarket Income REIT raised gross proceeds of £60 million in an issue.
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC
Centurion Shares to Resume Trading November 5
Trading in Centurion Minerals’ common shares is scheduled to resume on the TSX Venture Exchange at the market open on November 5, 2026. The company also provided an update on its o
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC
Euro Stoxx index falls 0.35%
Euro zone blue chips are down 0.37%.
M impact | EQUITY | Nov 03, 2026, 04:31 PM UTC